Biopticon Releases New Version of TumorManagerTM Program

January 5, 2012

Biopticon Corporation Announces the release of the new version of their innovative TumorManagerTM Program for managing pre-clinical oncology study data

Innovative instrument and software create revolutionary system to improve data, work-flow and results from in vivo cancer models

Princeton, NJ

Biopticon today released the latest version of their TumorManagerTM Program (version 1.3). It will be shown along with the TumorImagerTM at the American Association of Cancer Research (AACR) Exhibition in Chicago, IL in early April. This is the first major upgrade to the TumorManagerTM and incorporates many user requested enhancements making it the most flexible, powerful and easy to use pre-clinical oncology study management program available today.

Dr. Cem Girit, Founder and President, added “we greatly appreciate the ongoing feedback and innovative suggestions from our users and look forward to implementing many more of their ideas in future versions.”